Semaglutide 5 mg

Laboratory Test Result

Drug Description

Semaglutide is a peptide-based medication available in powder form, supplied in a 2 mL vial containing 5 mg of the active substance Semaglutide. It is manufactured by Dragon Pharma.

Semaglutide 5 mg Composition

Each vial contains 5 mg of Semaglutide.

Bodybuilding Benefits

Semaglutide is not commonly used in bodybuilding; rather, it is primarily prescribed to manage blood sugar levels in individuals with type 2 diabetes. Its benefits in bodybuilding, if any, are indirect and related to potential weight management effects.

Therapeutic Indication

Semaglutide is prescribed to improve glycemic control in adults with type 2 diabetes. It is a glucagon-like peptide-1 (GLP-1) receptor agonist that stimulates insulin secretion and reduces glucagon levels.

Dosage (Men)

The dosage for Semaglutide in the treatment of type 2 diabetes varies but is commonly initiated at 0.25 mg once weekly, gradually increasing to 1 mg weekly based on individual response and tolerability.

Dosage (Women)

Women with type 2 diabetes are generally prescribed a similar dosage range as men, with adjustments based on individual response and medical guidance.

Active Life

The active life of Semaglutide is prolonged, allowing for once-weekly administration in the treatment of type 2 diabetes.

Semaglutide 5 mg Side Effects

Common side effects may include nausea, vomiting, diarrhea, and abdominal pain. Serious side effects such as pancreatitis and allergic reactions are rare but possible.

Semaglutide 5 mg Contraindications/Precautionary Measures

Semaglutide is contraindicated in individuals with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Precaution is advised in those with a history of pancreatitis.

Overdosage

In case of overdosage, medical attention should be sought promptly. Symptoms may include severe nausea, vomiting, and hypoglycemia.

Semaglutide 5 mg Stack/Cycle

Semaglutide is not used in bodybuilding cycles or stacks due to its primary therapeutic application in managing type 2 diabetes.

Package Presentation

Semaglutide is presented in a 2 mL vial in powder form, containing 5 mg of the active substance.

Storage

Store Semaglutide as directed by the manufacturer, following the recommended storage conditions provided. Reconstitution and use should be in accordance with medical guidelines.

Semaglutide 5 mg Referrers